rs5174
A SNP in the LRP8 gene on chromosome 1. Its most notable genotype is T;T: 1.3x increased risk for heart disease
- Gene
- LRP8
- Location
- Chr 153,247,055 (GRCh38)
- Highest magnitude
- 2.0Worth knowing
- Tested on
- 23andMe, AncestryDNA, FamilyTreeDNA
- Minor allele frequency
- 18%
Genotypes
Plus strand, as in 23andMe and AncestryDNA files.
- T;TMost notableBad1.3x increased risk for heart disease
- C;TBad1.3x increased risk for heart disease
- C;CGoodNormal risk for heart disease
SNPedia records rs5174 on the minus strand: (A;A), (A;G), (G;G). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 10 HapMap populations.
- AverageT;T 3% C;T 20% C;C 77%
- European ancestry (Utah)T;T 20% C;T 48% C;C 33%
- Han Chinese (Beijing)T;T 0% C;T 7% C;C 93%
- Japanese (Tokyo)T;T 0% C;T 11% C;C 89%
- Yoruba (Nigeria)T;T 0% C;T <1% C;C 99%
- African ancestry (Southwest US)T;T 0% C;T 19% C;C 81%
- Chinese (Denver)T;T 0% C;T 3% C;C 97%
- Gujarati IndianT;T 1% C;T 27% C;C 72%
- Mexican ancestry (Los Angeles)T;T 0% C;T 31% C;C 69%
- Maasai (Kenya)T;T 0% C;T 4% C;C 96%
- TuscanT;T 11% C;T 46% C;C 43%
Related
Conditions, medicines and genes
Notes
From SNPedia
Show notes, about 200 words
rs5174 encodes a variant of the LRP8 gene, encoding the low density lipoprotein receptor-related 8 protein (or the apolipoprotein e receptor). The variant affects the protein, changing an arginine to a glutamine; depending on the publication, it can be referred to by terms like R952Q or Arg952Gln. In three Caucasian populations combined, the odds ratio for coronary artery disease or myocardial infarction (and thus heart disease) is 1.31 (adjusted p=0.0003). Note that this association was only seen in populations with familial and premature disease, as a study of 1,231 patients with primarily late-onset, sporadic heart disease did not show any correlation with this SNP. rs5174 (or its equivalent, rs5177) was analyzed in 1,210 patients with familial MI and 1,015 controls from the German MI Family study, in 1,926 familial CAD (1,377 with MI) patients and 2,938 controls from the Wellcome Trust Case Control Consortium (WTCCC) MI/CAD cohort, in 346 CAD patients and 351 controls from the AtheroGene study and in 295 men with incident CAD and 301 controls from the Prospective Epidemiological Study of MI study; no evidence was found for association in any of the populations studied.
Source and license
Adapted from rs5174 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.